eISSN: 2084-9834
ISSN: 0034-6233
Reumatologia/Rheumatology
Current issue Archive About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank
 
6/2011
vol. 49
 
Share:
Share:
more
 
 
abstract:
Case report

Acquired haemophilia A in a patient with rheumatoid arthritis

Stanisława Bazan-Socha
,
Joanna Zdziarska
,
Weronika Kleczyńska
,
Teresa Iwaniec
,
Jacek Musiał

Reumatologia 2011; 49, 6: 446–449
Online publish date: 2011/12/28
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Acquired haemophilia is a rare, life-threatening autoimmune disorder caused by inhibitory autoantibodies directed against various plasma clotting factors. In clinical practice, the most frequently observed are inhibitors of factor VIII – acquired haemophilia A. In about 50% of cases the disease develops in previously healthy subjects, in 35–40% it is secondary to autoimmune disorders, drug reactions or malignancy and in 10–15% it is associated with pregnancy and puerperium. Treatment of acquired haemophilia includes effective bleeding control and elimination of the inhibitor – the ultimate cure for the disease. Authors present a case of a 55-year-old patient with rheumatoid arthritis and acquired haemophilia A (Fig. 1, 2). The manifestations of haemorrhagic diathesis subsided after intravenous application of recombinant activated factor VII, prednisone and cyclophosphamide. The purpose of this report is to increase awareness of the possibility of acquired haemophilia as the reason of bleeding (especially subcutaneous) in patients with rheumatic diseases. Early diagnosis and proper treatment are critical for the disease outcome.
keywords:

acquired haemophilia, haemorrhagic diathesis, rheumatoid arthritis



Quick links
© 2020 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe